¶ Lorlatinib
100 mg tablets
Lorlatinib is a third generation TKI developed to treat ALK positive lung cancer with better brain penetration than previous treatments.
Pfizer marketed their product with the name Lorbrena. Visit the product's website at https://www.lorbrena.com .
¶ Dosage
The standard dosage is 100 mg per day. Dosage can be lowered to 75 mg per day or even 50 mg per day if needed. Any changes in dosage are at the discretion of your oncologist.
¶ Side Effects
There are several possible side effects from taking Lorbrena.
¶ Cost
Lorbrena costs between $21k and $22k per 30 day supply of 100 mg tablets.
¶ Financial Assistance
Pfizer offers a copay assistance of up to $10k per product per year. For more information and to apply, go to https://www.lorbrena.com/financial-assistance-info .